Crestline Management »

Dyne Therapeutics shares owned by Crestline Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Crestline Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 75k 28.39

More positions owned by Crestline Management

Denali Therapeutics (DNLI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Sana Biotechnology (SANA)
Asml Holding N V N Y Registry Shs (ASML)
NiSource (NI)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Kimberly-Clark Corporation (KMB)
Constellium Se Cl A Shs (CSTM)
PG&E Corporation (PCG)
Entergy Corporation (ETR)
PPL Corporation (PPL)
NVIDIA Corporation (NVDA)
Kellogg Company (K)
Arcosa (ACA)
Smucker J M Com New (SJM)

View all positions for Crestline Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Citadel Advisors
Deep Track Capital
FMR
State Street Corporation
Rtw Investments
TCG Crossover Management
T. Rowe Price Associates
Adage Capital Partners GP
VR Adviser

View all funds holding Dyne Therapeutics